Home General Biotechnology Drug Patent Expirations in November 2010

Drug Patent Expirations in November 2010

Drug Patent Expirations in November 2010

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent Number Patent Expiration
SAMSCAOtsuka America Pharmtolvaptan5,258,510Nov 2, 2010
TRUVADAGileademtricitabine; tenofovir disoproxil fumarate5,210,085*PEDNov 11, 2010
COZAARMercklosartan potassium5,210,079*PEDNov 11, 2010
EMTRIVAGileademtricitabine5,210,085*PEDNov 11, 2010
ATRIPLAGileadefavirenz; emtricitabine; tenofovir disoproxil fumarate5,210,085*PEDNov 11, 2010
TAXOTERESanofi Aventis Usdocetaxel4,814,470*PEDNov 14, 2010
GEMZARLillygemcitabine hydrochloride4,808,614*PEDNov 15, 2010
RAPAMUNEWyeth Pharms Incsirolimus5,212,155*PEDNov 18, 2010
FORTOVASEHoffmann La Rochesaquinavir5,196,438Nov 19, 2010
INVIRASEHoffmann La Rochesaquinavir mesylate5,196,438Nov 19, 2010
INVIRASERochesaquinavir mesylate5,196,438Nov 19, 2010
VITRAVENE PRESERVATIVE FREENovartisfomivirsen sodium5,264,423Nov 23, 2010
PEPCID ACMerck Sharp Dohmefamotidine5,075,114*PEDNov 23, 2010
PEPCID COMPLETEMerck Sharp Dohmecalcium carbonate; famotidine; magnesium hydroxide5,075,114*PEDNov 23, 2010
ADALAT CCBayer Hlthcarenifedipine5,264,446Nov 23, 2010
PROCARDIA XLPfizernifedipine5,264,446Nov 23, 2010
ARICEPT ODTEisai Incdonepezil hydrochloride4,895,841Nov 25, 2010
ARICEPTEisai Incdonepezil hydrochloride4,895,841Nov 25, 2010
HYCAMTINSmithkline Beechamtopotecan hydrochloride5,004,758*PEDNov 28, 2010
BUTRANSPurdue Pharma Lpbuprenorphine5,240,711Nov 28, 2010

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com

NO COMMENTS

Leave a Reply